[
    [
        {
            "time": "",
            "original_text": "价格低至1.5分，最高降幅达95%，194家药企角逐的第三批国采还有哪些看点？",
            "features": {
                "keywords": [
                    "价格",
                    "降幅",
                    "药企",
                    "第三批国采"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative",
                "price_sensitivity": "high",
                "market_competition": "intense",
                "regulatory_change": "true"
            },
            "scores": {
                "News_content": "价格低至1.5分，最高降幅达95%，194家药企角逐的第三批国采还有哪些看点？",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]